Meng Jia

机构：King University, Shandong University, Sirius University of Science and Technology, Nanjing University · ORCID：0000-0001-7135-2204

发表论文 25 篇 · 总被引 788 次 · h-index 13

代表论文

• PGRN acts as a novel regulator of mitochondrial homeostasis by facilitating mitophagy and mitochondrial biogenesis to prevent podocyte injury in diabetic nephropathy (2019 · Cell Death and Disease · 被引 166)
• Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma (2021 · Journal for ImmunoTherapy of Cancer · 被引 115)
• Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues (2017 · Human Pathology · 被引 75)
• Targeting tissue-resident memory CD8+ T cells in the kidney is a potential therapeutic strategy to ameliorate podocyte injury and glomerulosclerosis (2022 · Molecular Therapy · 被引 64)
• 32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma (2020 · Journal of Translational Medicine · 被引 54)
• Delivery of Anti-miRNA-221 for Colorectal Carcinoma Therapy Using Modified Cord Blood Mesenchymal Stem Cells-Derived Exosomes (2021 · Frontiers in Molecular Biosciences · 被引 49)